Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus. [electronic resource]
Producer: 19950615Description: 244-9 p. digitalISSN:- 1058-4838
- Adult
- CD4 Lymphocyte Count
- Dapsone -- therapeutic use
- Drug Therapy, Combination
- Female
- HIV Infections -- complications
- HIV-1 -- immunology
- Humans
- Immunocompromised Host
- Male
- Mycobacterium Infections -- prevention & control
- Mycobacterium avium-intracellulare Infection -- prevention & control
- Nebulizers and Vaporizers
- Pentamidine -- administration & dosage
- Pneumonia, Pneumocystis -- prevention & control
- Prospective Studies
- Pyrimethamine -- therapeutic use
- Retrospective Studies
- Toxoplasmosis, Cerebral -- prevention & control
- Tuberculosis, Pulmonary -- prevention & control
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.